Huhtamaki, a provider of sustainable packaging solutions, has embarked on a pioneering initiative to assess and mitigate ...
Arch Biopartners has dosed the first patient in Canada in its Phase II clinical trial of LSALT peptide (Metablok) for acute ...
Not a subscriber? Sign up for 30 days free access to exclusive, behind-the-scenes reporting on defense policy and procurement.